CD Genomics

CD Genomics operates as a specialized contract research organization (CRO) and service provider in the genomics space, offering an exceptionally wide array of sequencing and analysis technologies. The company serves as a one-stop shop for researchers requiring advanced genomic data generation, from standard whole-genome sequencing to niche services like single-cell epigenomics, CRISPR sequencing, and metagenomic shotgun sequencing. Its business model is purely service-based, catering to the R&D needs of client organizations rather than developing its own therapeutic or diagnostic products. With a strong online platform and global clientele, CD Genomics is positioned as a key enabler in the rapidly expanding research genomics market.

Platform-agnostic integrated service provider utilizing all major commercial sequencing technologies (Illumina, PacBio, Nanopore) and a comprehensive suite of omics and bioinformatics methods.

CD Genomics competes in a fragmented but crowded market. Key competitors include large, full-service CROs (e.g., Charles River, LabCorp), the service divisions of sequencing instrument companies (e.g., Illumina, Azenta), and numerous smaller boutique genomics service firms. Differentiation is achieved through breadth of services, technical expertise, and customer service.